Barricade Therapeutics, Corp. Email Format
Biotechnology ResearchTexas, United States2-10 Employees
Barricade Therapeutics is a clinical-stage biotechnology company developing precision EBP inhibitor therapeutics for colorectal cancer. Based in Dallas-Fort Worth, Texas, the company is advancing novel small molecule candidates designed to target key molecular pathways driving colorectal cancer progression. By integrating medicinal chemistry, molecular pharmacology, and translational oncology research, Barricade aims to address significant unmet need in colorectal cancer treatment.